Uni-Bio Science Group Limited (HKG:0690)
Hong Kong
· Delayed Price · Currency is HKD 0.1100
+0.0040 (3.77%)
Jul 16, 2025, 2:19 PM HKT
Uni-Bio Science Group Revenue
In the year 2024, Uni-Bio Science Group had annual revenue of 552.98M HKD with 14.08% growth. Uni-Bio Science Group had revenue of 279.37M in the half year ending December 31, 2024, with 14.15% growth.
Revenue
552.98M
Revenue Growth
+14.08%
P/S Ratio
1.14
Revenue / Employee
1.14M
Employees
487
Market Cap
632.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 552.98M | 68.26M | 14.08% |
| Dec 31, 2023 | 484.72M | 44.40M | 10.08% |
| Dec 31, 2022 | 440.32M | 86.91M | 24.59% |
| Dec 31, 2021 | 353.41M | 144.63M | 69.27% |
| Dec 31, 2020 | 208.78M | -673.00K | -0.32% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |
| CSPC Pharmaceutical Group | 28.99B |
Uni-Bio Science Group News
- 8 months ago - Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches : Pioneering Entry into the High-Growth Medical Aesthetics Market - Zawya